# LY75

## Overview
The LY75 gene encodes the lymphocyte antigen 75 protein, also known as CD205 or DEC-205, which is a type I transmembrane receptor primarily expressed on dendritic cells. This protein is a member of the mannose receptor family and plays a pivotal role in the immune system by mediating antigen uptake and presentation. The structure of lymphocyte antigen 75 includes multiple C-type lectin-like domains that facilitate receptor-mediated endocytosis, crucial for the internalization and processing of antigens for presentation on major histocompatibility complex (MHC) molecules. This function is essential for the activation of T cells, thereby initiating adaptive immune responses (Greenawalt2012Integrating; Nagasawa2013Identification). The protein's involvement in both innate and adaptive immunity underscores its significance in maintaining immune homeostasis and its potential as a target in cancer immunotherapy (Gil2020Systematic).

## Structure
The LY75 protein, also known as CD205 or DEC-205, is a type I transmembrane protein involved in antigen processing and presentation. Its molecular structure includes several conserved domains. The protein features a signal peptide at the N-terminus, which is crucial for directing the nascent protein to the secretory pathway (Nagasawa2013Identification). The extracellular region of LY75 contains multiple C-type lectin-like domains, which are important for binding carbohydrates and facilitating receptor-mediated endocytosis (Greenawalt2012Integrating). These domains are characteristic of proteins involved in immune responses, particularly in antigen uptake.

The protein also includes a transmembrane domain, which anchors it to the cell membrane, allowing it to function as a receptor (Nagasawa2013Identification). Post-translational modifications such as glycosylation are likely, given the presence of C-type lectin domains, which often undergo such modifications to enhance stability and function. The LY75 gene may produce different isoforms through alternative splicing, although specific isoforms are not detailed in the provided context. The structure of LY75, with its combination of lectin domains and a transmembrane region, supports its role in the immune system, particularly in dendritic cells where it is primarily expressed (Greenawalt2012Integrating).

## Function
The LY75 gene, also known as lymphocyte antigen 75 or DEC-205, encodes a type I transmembrane protein that is part of the mannose receptor family. This protein is predominantly expressed on dendritic cells (DCs) and plays a critical role in the immune system by facilitating antigen uptake and presentation. LY75 is involved in endocytosis, where it internalizes antigens and processes them for presentation on major histocompatibility complex (MHC) class I and II molecules. This process is essential for the activation of CD8+ and CD4+ T cells, which are crucial for initiating adaptive immune responses (Gil2020Systematic).

In healthy human cells, LY75 is active in endocytic pathways, where it aids in the phagocytosis of pathogens and the presentation of antigens to T cells. This function is vital for maintaining immune tolerance and generating cytotoxic T lymphocytes, which are important for eliminating infected or cancerous cells (Gil2020Systematic). The expression of LY75 on DCs is also linked to the infiltration and activation of natural killer (NK) cells, enhancing their cytolytic activity against tumor cells (Gil2020Systematic). This highlights LY75's role in both innate and adaptive immunity, contributing to the organism's overall immune defense mechanisms.

## Clinical Significance
Alterations in the expression and function of the LY75 gene have been implicated in various diseases, particularly in cancer and hematopoietic disorders. In skin cutaneous melanoma (SKCM), LY75 expression is significantly downregulated, which correlates with poorer patient survival rates. This downregulation is associated with increased DNA methylation of the LY75 gene, suggesting an epigenetic mechanism contributing to melanoma progression by potentially inactivating tumor suppressor genes (Gil2020Systematic). Higher LY75 expression is linked to better prognosis in SKCM, likely due to its role in enhancing immune cell infiltration, including natural killer (NK) cells, which are crucial for anti-tumor responses (Gil2020Systematic).

In the context of clonal hematopoiesis, LY75 variants have been associated with a reduced risk of DNMT3A clonal hematopoiesis of indeterminate potential (CHIP). Specific missense variants in LY75 are thought to confer a protective effect against this condition, highlighting its potential as a therapeutic target for managing clonal hematopoiesis (Kessler2022Common; Kessler2022Exome). These findings underscore the clinical significance of LY75 in both cancer and hematopoietic disorders, suggesting its potential as a biomarker and therapeutic target.

## Interactions
LY75, also known as CD205 or DEC-205, is a receptor involved in various interactions crucial for immune responses. It is primarily expressed on dendritic cells and plays a significant role in antigen uptake and presentation. LY75 is part of the mannose receptor family and is involved in processes such as phagocytosis, endocytosis, and antigen presentation (Gil2020Systematic).

LY75 interacts with several proteins and ligands. It can bind bacterial ligands, oxidized low-density lipoprotein (oxLDL), and apoptotic cells, facilitating the internalization of antigens to the endo/lysosome in thymic epithelial cells and dendritic cells (Del2019Sensing). This interaction is crucial for the clearance of apoptotic thymocytes and the modulation of immune responses. The receptor is characterized as a death-sensing receptor that recognizes apoptotic and necrotic cells, with binding being pH-dependent (Del2019Sensing).

In the context of cancer, particularly skin cutaneous melanoma, LY75 expression is associated with the infiltration and activation of natural killer (NK) cells. It enhances the expression of activating receptors on NK cells, such as KLRK1 (NKG2D), NCR1 (NKp46), NCR2 (NKp44), NCR3 (NKp30), and FASLG (Fas ligand), which are crucial for NK cell activation and the induction of apoptosis in tumor cells (Gil2020Systematic). These interactions highlight LY75's role in regulating immune cell activity and its potential as a target for cancer immunotherapy.


## References


1. (Kessler2022Exome) Exome sequencing of 628,388 individuals identifies common and rare variant associations with clonal hematopoiesis phenotypes. This article has 14 citations.

[2. (Greenawalt2012Integrating) D. M. Greenawalt, S. K. Sieberts, M. C. Cornelis, C. J. Girman, H. Zhong, X. Yang, J. Guinney, L. Qi, and F. B. Hu. Integrating genetic association, genetics of gene expression, and single nucleotide polymorphism set analysis to identify susceptibility loci for type 2 diabetes mellitus. American Journal of Epidemiology, 176(5):423–430, August 2012. URL: http://dx.doi.org/10.1093/aje/kws123, doi:10.1093/aje/kws123. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/aje/kws123)

[3. (Nagasawa2013Identification) Kazue Nagasawa, Jorge M.O. Fernandes, Goro Yoshizaki, Misako Miwa, and Igor Babiak. Identification and migration of primordial germ cells in atlantic salmon, salmo salar: characterization of vasa, dead end, and lymphocyte antigen 75 genes. Molecular Reproduction and Development, 80(2):118–131, February 2013. URL: http://dx.doi.org/10.1002/mrd.22142, doi:10.1002/mrd.22142. This article has 70 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/mrd.22142)

[4. (Del2019Sensing) Carlos Del Fresno, Francisco J. Cueto, and David Sancho. Sensing Tissue Damage by Myeloid C-Type Lectin Receptors, pages 117–145. Springer International Publishing, 2019. URL: http://dx.doi.org/10.1007/82_2019_194, doi:10.1007/82_2019_194. This article has 3 citations.](https://doi.org/10.1007/82_2019_194)

[5. (Gil2020Systematic) Minchan Gil and Kyung Eun Kim. Systematic multiomic analysis of ly75 gene expression and its prognostic value through the infiltration of natural killer (nk) cells in skin cutaneous melanoma. Journal of Clinical Medicine, 9(5):1383, May 2020. URL: http://dx.doi.org/10.3390/jcm9051383, doi:10.3390/jcm9051383. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jcm9051383)

[6. (Kessler2022Common) Michael D. Kessler, Amy Damask, Sean O’Keeffe, Nilanjana Banerjee, Dadong Li, Kyoko Watanabe, Anthony Marketta, Michael Van Meter, Stefan Semrau, Julie Horowitz, Jing Tang, Jack A. Kosmicki, Veera M. Rajagopal, Yuxin Zou, Yariv Houvras, Arkopravo Ghosh, Christopher Gillies, Joelle Mbatchou, Ryan R. White, Niek Verweij, Jonas Bovijn, Neelroop N. Parikshak, Michelle G. LeBlanc, Marcus Jones, David J. Glass, Luca A. Lotta, Michael N. Cantor, Gurinder S. Atwal, Adam E. Locke, Manuel A. R. Ferreira, Raquel Deering, Charles Paulding, Alan R. Shuldiner, Gavin Thurston, Adolfo A. Ferrando, Will Salerno, Jeffrey G. Reid, John D. Overton, Jonathan Marchini, Hyun M. Kang, Aris Baras, Gonçalo R. Abecasis, and Eric Jorgenson. Common and rare variant associations with clonal haematopoiesis phenotypes. Nature, 612(7939):301–309, November 2022. URL: http://dx.doi.org/10.1038/s41586-022-05448-9, doi:10.1038/s41586-022-05448-9. This article has 121 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41586-022-05448-9)